San Raffaele Hospital, Milan
17-beta-estradol-eluting stent was not superior to phosphorylcholine-coated stent
Published in Cardiovascular Device Liability Week, November 6th, 2005
According to researchers in Italy, "In [our] study we randomly compared the estradiol-eluting stent (17-beta-E) with phosphorylcholine (PC)-coated stents in native coronary arteries."
F. Airoldi and colleagues of the San Raffaele Hospital in Milan reported, "The incidence of angiographic restenosis was 23% in the 17-beta-E group and 31% in the PC group (p=0.34). The major adverse cardiovascular event rates were also similar in the 2 groups (17% in the 17-beta-E group vs. 22% in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Allgemeines Krankenhaus St. Georg, Hamburg
3-D electroanatomical mapping aids isolation of veins for treatment of atrial fibrillation - California Birth Defects Monitoring Program, Berkeley
NPPA appears to be a good candidate gene for conotruncal defects - National Research Council Canada, Ottawa
Adenoviral vector shows promise as an investigational tool when looking at neuronal damage - Whitehead Institute for Biomedical Research
Researchers offer proof-of-concept for altered nuclear transfer - Aastrom Biosciences, Inc.
Tissue repair cells used in trial for regeneration of vascular tissue in diabetic patients - Academic Medical Center, Amsterdam
Patient-activated loop recorders improve primary care diagnosis of cardiac arrhythmias - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
